I remain invested here too.
Strong demand push in new programs
- From 4 new customer programs were 3 were asked to double their production capacity.
- This indicates surprisingly high demand and accelerated scaling.
Second half of the year expected to pick up significantly
- Management expects a clear ramp-up in H2as several major programs enter the ramp-up phase phase.
- MedTech programs in particular are driving growth.
Capacity expansion already underway
- UFP is investing in additional machines, automation and production spaceto enable the requested doubling of capacity.
- Focus on efficiency and margin stability despite expansion.
Strategic importance of the new programs
- The programs are among key products for major MedTech customers.
- Long-term sales quality: High visibility, multi-year terms, high margins.
Overall message
- Short-term: Expenses due to capacity expansion.
- Medium-term: Significantly higher sales level and margin leverageas soon as the programs are running at full capacity.
